Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2011-02-10 |
| Study Made Public: | 2012-02-14 |
Title
Screening of gp41-HR1 based antigens for ability to elicit neutralizing antibodies
Description
CAVD 342 is a preclinical guinea pig study investigating different prime-boost combinations of gp41-HR1 liposomes or peptide mimetics compared to control immunizations (R2 (Clade B), CN54 (Clade C) or SF162 (Clade B) gp140s.
Sign in to see full information about this study and to download study data.
Products
PEI CN54env-gp140 R2env-gp140 gp41 5HB gp41 HR1 SF162env-gp140 SYM767 SYM997Integrated data
NAb
Non-integrated data
No non-integrated data is available for this study.